(1 reference)-
- Target Alle RBP3 Produkte
- RBP3 (Retinol Binding Protein 3, Interstitial (RBP3))
- Protein Region
- AA 1-20
- Reinheit
- > 95 %
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- -20 °C
-
-
: "Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 22, Issue 12, pp. 2069-82, (2014) (PubMed).
-
: "Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 22, Issue 12, pp. 2069-82, (2014) (PubMed).
-
- Target
- RBP3 (Retinol Binding Protein 3, Interstitial (RBP3))
- Synonyme
- Irbp Peptide, Rbp-3 Peptide, D10S64 Peptide, D10S65 Peptide, D10S66 Peptide, IRBP Peptide, RBPI Peptide, RP66 Peptide, retinol binding protein 3 Peptide, interphotoreceptor retinoid-binding protein Peptide, retinol binding protein 3, interstitial Peptide, rbp3 Peptide, RBP3 Peptide, glr2547 Peptide, XOO2681 Peptide, AMED_0162 Peptide, ambt_08395 Peptide, Rbp3 Peptide
- Hintergrund
- This peptide consisting of residues 1-20 of human interphotoreceptor retinoid binding protein peptide (IRBP) has been shown to induce posterior uveitis (EAU) in several studies. Experimental autoimmune uveitis is an animal model for endogenous human posterior uveitis.
-
Sie sind hier:
